BACKGROUND: Poor medication adherence is a predictor of poor health outcomes, especially in populations with chronic diseases. Although several self-reported measures of medication adherence exist, the scope of each is limited.
The sample population included Medicare Part D patients receiving MTM services from the Medication Management Center (MMC) at the University of Arizona. In order to participate, patients had to be members of organizations contracting with the MMC and nonadherent for an antilipidemic, antihypertensive, or antidiabetic agent. For this study, nonadherence was considered less than 80% of proportion of days covered (PDC) in a 180-day measurement period for prescription claims for the same medication or another medication in the respective therapeutic class. Purposive sampling was used to identify the sample population for this study. In particular, several chronic conditions were identified (hyperlipidemia, hypertension, and diabetes) that may require patients to take prescription medications. Among patients with these diagnoses, the investigators wanted to recruit nonadherent patients to investigate reasons why they were unable or unwilling to follow the prescribed regimens. Additional inclusion criteria for participation in this study were ability to speak English and to manage medications. If participants were not in charge of their medications, consent to contact their caregivers was obtained. Study participation required patients to spend additional time on the telephone to respond to the survey items after completing their originally scheduled MTM consultation. However, study participation was voluntary, and subjects did not receive compensation. The University of Arizona Institutional Review Board approved this study.
Adherence Instrument
A 20-item questionnaire was specifically designed for this study to explore reasons for medication nonadherence. The survey included items in open-ended, dichotomous, and multiple-choice formats. The items elicited information regarding the following: (a) medical conditions for taking prescription medications; (b) problems associated with obtaining prescriptions from a pharmacy or via mail order; (c) prescription medications and reasons for not obtaining prescriptions; (d) prescription medications and reasons for not using as prescribed; (e) reasons for starting and then stopping prescription medications; and (f) demographic information.
The initial open-ended item verified the medical conditions for which the beneficiary was taking prescription medications. A second open-ended item asked respondents to describe any problems encountered in obtaining their medications. Next, a dichotomous item asked whether subjects received their medications via mail order pharmacy. If participants responded affirmatively, they were asked if they encountered any problems obtaining their medications through this mechanism. The next set of dichotomous items were developed to distinguish between beneficiaries who never picked up their prescriptions, those who obtained their prescriptions but never used them, and those who started taking their medications but stopped during the previous 3 months. If a beneficiary responded found that only about half of patients with chronic conditions take their medicines routinely as directed. 11 Most seniors have 1 or more chronic conditions that require multiple medications (polypharmacy). 12 Cost-related nonadherence (CRN) presents another challenge. Despite initiation of the Medicare Part D program, one-eighth to one-third of all seniors report CRNrelated issues. [13] [14] [15] [16] Currently, some older adults receiving Medicare Part D benefits are eligible for medication therapy management (MTM) services such as counseling and education related to medication adherence. Research shows MTM services are effective in decreasing medication problems and hospital readmission rates. [17] [18] [19] [20] [21] [22] Additionally, pharmacist services (e.g., MTM and patient education) decrease hospital admissions (up to 30%), 23, 24 emergency department visits (up to 24%), 24, 25 and overall health care expenditures. 26, 27 Despite these efforts, 4%-40% of all Medicare beneficiaries are nonadherent to prescribed medication regimens. 28, 29 Several instruments measure medication adherence and patients' beliefs about their medications. 30 Yet, to the authors' knowledge, none of these instruments considers an important factor: the effect of patients' pharmacy-related experiences (e.g., costs, convenience, access, use of mail-order) on medication adherence.
Surveying patients about their medication nonadherence may be uncomfortable for some individuals. Telephone interviews, commonly used in quantitative research, may allow participants to be relaxed and more able and willing to share sensitive information. 31 To date, most of the adherence-related questionnaires are designed for mail, electronic, or face-toface, rather than telephone, administration. Moreover, visual analogue scales that have demonstrated valid results may not be appropriate for telephonic administration. 30 Telephonic surveys allow participant contact despite geographically dispersed locations, are generally shorter in length, and take less time to administer than other types of survey methods (e.g., face-to-face interviews) 31 ; however, they require special scripts with skip patterns, brevity in the number of items, and formal training of interviewers to ensure consistency in administration and data. Yet, the advantages outweigh the disadvantages when collecting sensitive health-related information.
The purpose of this cross-sectional study was to identify barriers to medication adherence to facilitate effective delivery of telephone-based MTM services to beneficiaries of contracted Medicare Part D plans.
■■ Methods Study Design and Target Population
This study employed a cross-sectional design to elicit reasons for nonmedication adherence among contracted Medicare Part D beneficiaries receiving MTM services. affirmatively to any of these questions, the interviewer asked for identification of each medication and the reasons for (a) not obtaining, (b) obtaining and not taking, or (c) starting and then stopping the prescribed regimens. Finally, the instrument included 5 items to measure beneficiary beliefs about medications, and 4 items assessed participant demographic information. The items measuring medication beliefs were adapted from a previous survey (see Appendix, available in online article, for more details on the telephone survey), as brief instruments suitable for telephone administration were found in the literature. 32 A 4-point Likert scale was employed to measure participant disagreement or agreement with each statement in the Beliefs About Medication Use subscale (1 = strongly disagree; 2 = disagree; 3 = agree; 4 = strongly agree). Prior to data collection, the questionnaire was pilot tested with 3 pharmacists initially and subsequently with 10 patients to ensure clarity and content validity. The questionnaire was revised accordingly after the pilot testing.
Modified Beliefs About Medication Use Subscale: Rasch Analysis
Rasch analyses were conducted to assess item validity and reliability of the Beliefs About Medication Use items. Infit and outfit mean-squares (MNSQ) statistics were used to determine the construct relevance of the items in the Beliefs About Medication Use subscale. Infit MNSQ statistic is sensitive to item difficulty and participant's ability, while outfit MNSQ is more sensitive to extreme responses. In this study, if an item infit was placed between 0.6 and 1.4, it was considered to fit the model appropriately. Values below this range may indicate item redundancy, and values above this range might indicate multidimensionality. 33 A difference of 0.5 logits or higher on the measured scale between adjacent items was deemed an important gap in item content. 34 Rasch analyses were used to evaluate the 4-point Likert-type scale used to measure participant disagreement or agreement regarding beliefs about medications statements. The rating scale analysis requires (a) at least 10 observations per category (category frequency); (b) observations that distribute appropriately across categoriesthat is, the probability curve for each category should have its own peak; (c) average measures that advance monotonically with category; (d) outfit mean squares that are less than 2; (e) step calibrations that advance; (f) rating to measure coherence; and (g) step difficulties advance greater than or equal to 1.4 logits and less than 5 logits. Finally, reliability of the subscale of participant beliefs about medications was assessed with the Rasch person separation and reliability indices, with values over 2 and 0.8, respectively, considered as adequate. 35 This study targeted a minimum sample of 100 participants to obtain robust parameter estimates of this subscale.
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Data Collection and Analysis
Two pharmacy students in their final year of pharmacy school conducted the survey interviews at the MMC with eligible patients. To ensure consistency in data collection procedures and reduce the potential for bias, both interviewers completed a formal training session conducted by the investigator (Boesen); additionally, the interviewers used a scripted survey with skip patterns.
The telephone questionnaire was administered after completion of the beneficiary's scheduled MTM consultation. Participation in the survey was voluntary. Initially, the trained interviewer determined if the beneficiary met the eligibility criteria. Next, the interviewer asked if the eligible beneficiary was interested in participating in the research study. If the beneficiary responded affirmatively, the interviewer followed the 
TABLE 1
Participant Demographic Characteristics informed consent procedures and answered any questions. If the beneficiary was unable to respond to the survey items (e.g., knowledge deficit, physical/emotional limitations), the authorized caregiver was asked to participate on the beneficiary's behalf. For those choosing not to participate, the interviewer thanked the beneficiary and ended the call.
Prior to beginning the telephone survey, the trained interviewer identified the prescription medications, via pharmacy claims data, prescribed for the eligible beneficiary. The trained interviewer then proceeded to administer the survey, which took approximately 15 minutes to complete. The telephone interviews were conducted between September 2012 and February 2013.
Summary statistics were calculated for each of the questionnaire items using STATA 12 (Statacorp, College Station, TX). Rasch analyses were conducted using WINSTEPS version 3.71.0.1 (Winsteps.com, Queensland, Australia).
■■ Results Patient Demographic Characteristics and Medication Use: Descriptive Statistics
A total of 124 patients participated in the survey. Of those completing the telephone survey, the majority were patients (97.6%); only 3 surveys (2.4%) were completed by caregivers. The sample population had a mean age of 69.8 years (standard deviation = 9.9), and more than half of the participants (60.4%) were female. More than half (58.0%) of patients surveyed were married, while approximately three-quarters were retired or not working (74.5%) and had completed a high school education (71.6%; Table 1) .
A small proportion of participants (19.0%) received their medications by mail. Medication nonadherence, defined as a PDC lower that 80%, generated alerts mostly associated with antilipidemic agents (n = 53, 42.7%), followed by antihypertensive drugs (n = 43, 34.6%) and antidiabetic medications (n = 28, 22.5%). Table 1 summarizes the most common medications within each category. Only 5 respondents (4.0%) selfreported medical conditions where prescription medications were used; these conditions included high cholesterol, diabetes, hypertension, hypothyroidism, and chronic obstructive pulmonary disease.
Beliefs About Medication Use: Descriptive Statistics
The majority (57.8%) of participants indicated they did not worry about future problems with their medications, and nearly two-thirds (69.3%) were not worried about taking medications. Four-fifths of participants (84.2%) indicated they could not live without their medications, and the vast majority (93.2%) either strongly agreed or agreed that their medicines keep them healthy. Most respondents (95.7%) strongly agreed or agreed that their medications were "easy to use" ( Table 2 ).
Modified Beliefs About Medication Use Subscale: Rasch Analysis
The functioning of the rating scale was examined. There were at least 10 observations per category. However, the frequency distribution (Figure 1 ) indicated that the "disagree" response option was problematic given that it failed to reach the 0.5 probability threshold of being selected. Collapsing the "strongly disagree" and "disagree" categories produced a better fit to the model (Table 3) . Rasch analysis was also performed to assess the extent that each item in the scale contributed to the model fit. All items fell inside the acceptable Rasch model fit criteria (0.6-1.4 logits), indicating the absence of overfitting or misfitting items ( Table 2 ). The hardest item to endorse by participants was "I do not worry about the future problems of my medicines," while the easiest item to endorse was "My medicines are easy to use." There was a significant content gap between the item "I do not worry about the future problems of my medicines" and "I worry about taking medicines," since the difference in logits of the item measures was greater than 0.5 ( 
Frequency of Participant Responses for Beliefs Regarding Medication Use Items and Rasch Analysis Summary of Item Properties
indices for the model were 0.46 and 0.90, respectively. These indices fell below the accepted threshold values of 0.8 and 2 correspondingly, indicating that the subscale was not able to discriminate between different levels of respondents' beliefs about medications.
Reasons for Medication Nonuse or Discontinuation: Descriptive Statistics and Qualitative Results
Almost half (n = 60, 48.3%) of all participants reported never obtaining, obtaining but not using, or starting but stopping prescribed medications. The most frequently cited reasons for not obtaining their prescribed medications (n = 12) were cost (25.0%) and the pharmacy staff telling them the prescription was already picked up (16.7%), followed by transportation, unavailability of medication, use of samples, and purchasing medications abroad (8.3% for each reason). Two participants (16.7% of respondents) provided no reason (Table 4) .
Participants who obtained but did not use their medications (n = 13) reported medication-related problems (38.5%) most frequently, followed by non-necessity for condition (15.3%) and felt better so did not need medicine (15.3%). Four participants (30.7%) provided no reason.
Participants who reported starting then stopping their medications (n = 35) cited these reasons most frequently: medication side effects (40.0%), physician switched medication (34.3%), and felt better so did not need medicine (11.4%). Only 4% of the medications identified by respondents as problematic corresponded to the medication triggering the alert based on the claims data. The medications that patients were referring to while answering the previously mentioned questions are presented in Table 4 .
■■ Discussion
This telephone study assessed beliefs and practical barriers to medication adherence. Most participants reported positive beliefs about medications and did not report adherence issues related to the triggering medications. It is encouraging that patients failed to report negative medication beliefs, especially since these viewpoints are difficult to change. However, every patient contacted was surveyed because the retrospective claims data indicated an adherence problem for a trigger medication (i.e., an antilipidemic, antihypertensive, or antidiabetic agent); yet, most did not seem to acknowledge their nonadherence.
Patients were identified based on their PDC. The PDC is a method of determining medication adherence endorsed by the Pharmacy Quality Alliance and the Centers for Medicare & Medicaid Services. 36, 37 PDC assesses the available days' supply of a medication across an interval of time; the previous 180-day interval was used for this study. Other adherence measures are available; however, the PDC was our preferred choice given our Medicare population. 38 The data available to determine PDC included covered Medicare claims as well as any claims associated with any other gap coverage that the patients may have had.
Of interest in this study is the number of patients that, despite a PDC less than 80%, failed to acknowledge their gap in adherence. A potential explanation is a gap in claims due to cash-paid prescriptions or even the use of medication samples. However, both of these gaps would have emerged during the structured medication reconciliation completed with the patient.
The most frequently cited reasons for not obtaining prescribed medications (n = 12) were cost (25.0%) and the pharmacy staff saying that the prescription was already picked up (16.7%), followed by transportation, unavailability of Nonetheless, most of the reported barriers were practical in nature and easily resolved. For example, some patients cited lack of transportation for not obtaining their medications. Assisting patients with signing up for and obtaining prescriptions via mail order or home delivery by community pharmacies may provide a viable solution to the transportation issue. However, many patients cited cost as an issue for not obtaining their prescription medications. Making changes in health care policies to ensure affordable prescription medications for all patients is a much more complex issue. To address the cost issue, pharmacists can help these patients switch to a lowercost therapeutic alternative.
Participants who obtained but did not use their medications most frequently reported medication-related problems (38.5%) for nonadherence. There are several potential opportunities to address this issue via existing MTM services. Improving communication between the primary care provider, pharmacist, and patient could help resolve this issue simply by prescribing an alternative medication with fewer side effects. Additionally, almost one-third (30.6%) of participants cited non-necessity for condition and feeling better so did not need medicine as reasons for not taking their medications. These issues are also manageable as a component of a patient engagement/education program (MTM intervention) focusing on the importance of taking medications as prescribed for chronic conditions to prevent disease progression, treatment failure, and other more serious consequences. medication, use of samples, and purchasing medications abroad (8.3% for each reason). Two participants (16.7%) provided no reason (Table 4) . This sample population reported nonadherence to newly prescribed medications that parallel findings from other published studies. 39, 40 Yet, pharmacists are in a unique position to help these patients overcome adherence-related barriers to improve health-related outcomes.
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There are several likely reasons why patients failed to acknowledge their nonadherence. It is possible that, for some patients, the adherence gaps were closer to the beginning of the 6-month measured interval, and they had recently become more adherent. However, it is more likely that a lack of knowledge existed relative to their own PDC. Also, patients in this study had a minimum of 8 chronic medications prescribed to treat a number of conditions. While it is feasible that they could adhere to most regimens, missing as few as 3 doses over a 2-week period would reduce the PDC for a specific medication below the adherence threshold. The complexity of managing multiple chronic illnesses is potentially too burdensome, especially without access to some type of personal support (e.g., caregiver, friend, or family member). Thus, patients may not notice their own gaps in therapy.
Patients did report adherence issues, albeit not for the triggering medications. Most of the medications were for treating short-term conditions or conditions where manifestation of symptoms was more evident for patients. It is possible that some respondents were hospitalized during the previous 180 days, thus, affecting their responses for multiple reasons (e.g., too sick to recall events, confusion about inpatient/outpatient medications). Further research is required to ascertain whether patient awareness and understanding of medication adherence • Patient thought medicine cost too much (n = 3)
• Patient took the medicine and it gave him/her problems-side effects (n = 14)
• Patient felt better so didn't need medicine (n = 4)
• Physician switched the medication (n = 12)
• Patient thought insurance stopped the medicine (n = 1) Medications Self-Reported in this Category • Acarbose, atorvastatin, furosemide, naproxen, sitagliptin, oxycodone, others (unknown)
Medications Self-Reported in this Category
• Insulin lispro, Clarithromycin, levalbuterol, lorazempan, paroxetine, tramadol, ezetimibe, glibenclamide, hydrocodone, phosphate binder, tiotropium bromide, unidentified eye drops, others (unknown)
• Acarbose, celecoxib, cholestyramine, eye drops, fluvastatin, furosemide, gabapentin, hydrochlorothiazide, lisinopril, nitrofurantoin, oxymorphone, pravastatin, pramipexole, simvastatin, sitagliptin, tiotropium bromide, tramadol, trazodone, zolpidem 
Limitations
This study was subject to several limitations. First, this study used a cross-sectional design. This type of study design is advantageous given that it does not require follow-up so is less expensive and has a shorter implementation timeline. However, a disadvantage of a cross-sectional design is that it excludes the long-term follow-up needed to determine whether participant behaviors or actions are maintained or deteriorate over time. Second, the authors recognize the small sample size is a study limitation and that the results are not generalizable to all Medicare Part D patients receiving MTM services. However, an advantage of the smaller sample size is that it enabled the researchers to gain some valuable insight into problems associated with medication adherence. These study results are encouraging and will serve to inform future projects with larger patient/beneficiary populations.
Third, another study limitation is response bias. Given that beneficiaries were asked about a sensitive matter with a negative connotation (nonadherence), it is plausible they may have underreported reasons for nonadherence to prescribed medication regimens. That is, beneficiaries may have only reported 1 reason for nonadherence when in actuality there were multiple reasons. Alternatively, they may have chosen to report a more socially desirable reason (e.g., cost) rather than a less desirable one (e.g., transportation). However, using a telephone survey method may have helped counteract response bias by providing a safe and more relaxed environment for beneficiaries to share sensitive information. 31 
■■ Conclusions
This study identified reasons for medication nonadherence among a sample population of Medicare Part D beneficiaries receiving MTM services via a university-based medication management center. Most participants reported positive beliefs about medications and did not report adherence issues related to the triggering medications. MTM programs are in a unique position to raise awareness about the importance of medication adherence among their members. To remain at the forefront, MTM programs must offer potential solutions to a number of the barriers to medication adherence to improve patient health and safety.
Participants who reported starting then stopping their medications most frequently cited medication side effects, physician switched medication, and felt better so did not need medicine. Again, these reasons for nonadherence may be addressed by MTM services. Pharmacists could recommend that the provider prescribe another equally effective alternative medication and educate the beneficiary about improving chronic disease prognosis and overall health.
Medication nonadherence is a serious problem with possible life-threatening consequences. As observed in this study, patients frequently are unable to recognize their own adherence issues, especially for chronic medications. Thus, it is imperative for MTM programs to first identify population-specific medication adherence barriers and subsequently offer more effective and efficient solutions. Additionally, these programs have a unique opportunity to raise awareness about the importance of medication adherence among their members. This would not only benefit patients, it would also enhance Medicare Part D plan performance on CMS medication adherence star ratings. 41 Currently, CMS uses 3 medication adherence (Part D) performance measures: oral antidiabetic medications, antihypertensive agents (renin-angiotensin system antagonists), and cholesterol medications (statins). While these measures are important for Part D ratings, they also contribute to a health plan's Part C ratings for diabetes care (blood sugar and cholesterol control) and hypertension control. 42 Thus, it is imperative that health care providers, pharmacists, health educators, and health care decision makers align themselves to develop effective policies and programs to improve patient adherence so as to reduce health care utilization and its associated costs.
The Rasch analyses results showed the need for combining 2 categories (strongly disagree and disagree) to fit the model, since 1 category (disagree) was rarely observed. This suggests that the 4-point rating scale functioned less than ideally in this sample population. There are multiple reasons that may explain why this occurred. It may have been difficult for participants to differentiate between the rating scale anchor of strongly disagree and disagree. In this case, using a rating scale with fewer points (i.e., 3 points) may work better. Alternatively, this study included a relatively small sample size; however, it is feasible that in a larger study sample the selection frequency of the disagree category would be higher, thus, eliminating the need to collapse these 2 categories. Additionally, participants had difficulty endorsing the item "I do not worry about the future problems of my medicines." Several explanations may account for this phenomenon. First, the use of double negative wording in the statement may have been confusing. Second, it is possible that participants were unable to foresee or may have not understood the potentials side effects of their medicines. The person separation and reliability indices were below DISCLOSURES Kevin Boesen is employed by SinfoniaRx. The authors declare no other potential conflicts of interest.
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